Journal Information
Vol. 46. Issue S9.
Terapias emergentes en el tratamiento de EPOC
Pages 8-11 (November 2010)
Share
Share
Download PDF
More article options
Vol. 46. Issue S9.
Terapias emergentes en el tratamiento de EPOC
Pages 8-11 (November 2010)
Full text access
Roflumilast: revisión clínica de una nueva opción para el tratamiento de la inflamación en la EPOC
Visits
7437
Fernando J. Martínez
University of Michigan Health System. Estados Unidos
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
D.C. Grootendorst, S.A. Gauw, R.M. Verhoosel, P.J. Sterk, J.J. Hospers, D. Bredenbröker, et al.
Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD.
Thorax, 62 (2007), pp. 1081-1087
[2.]
P.M. Calverley, F. Sanchez-Toril, A. McIvor, P. Teichmann, D. Bredenbroeker, L.M. Fabbri.
Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 176 (2007), pp. 154-161
[3.]
Calverley PMA, Martínez FJ, Goehring UM, Rennard SI. Defining patient populations in COPD: experience with roflumilast. Presented at: 7th International Multidisciplinary Conference on Chronic Obstructive Pulmonary Disease (COPD7). Birmingham, UK, 30 June-2 July 2010 (Poster 48).
[4.]
P.M. Calverley, K.F. Rabe, U.M. Goehring, S. Kristiansen, L.M. Fabbri, F.J. Martinez, et al.
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.
[5.]
L.M. Fabbri, P.M. Calverley, J.L. Izquierdo-Alonso, D.S. Bundschuh, M. Brose, F.J. Martinez, et al.
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.
[6.]
N.A. Hanania, M. Brose, T. Larsson, K.F. Rabe.
Efficacy of roflumilast in patients receiving concomitant treatments for Chronic Obstructive Pulmonary Disease over 12 months.
Am J Respir Crit Care Med, 181 (2010), pp. A4435
[7.]
E.F.M. Wouters, P. Teichmznn, M. Brose, K.F. Rabe, L.M. Fabri.
Effects of roflumilast a phosphodiesterase 4 inhibitor, on body composition in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 181 (2010), pp. A4473
Copyright © 2010. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?